Frank X. Leonard, Chief Development Officer at NovoCure Ltd (NVCR), sold 19,025 shares at $87.31 ($1.7M) on 2022-09-15, disclosed to the SEC on 2022-09-19.
Open-market sale of $1.7M NVCR by Chief Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $87.31 | 6,754 | $590K | 35.2% |
| 2 | $87.31 | 6,754 | $590K | 35.2% |
| 3 | $90.00 | 5,517 | $497K | 29.6% |
| Total | $88.09 avg | 19,025 | $1.7M | 100% |
| Filing → |
| NVCR | SELL | 2026-03-03 | $231K | — | Filing → |
| NVCR | SELL | 2025-06-04 | $1.0M | — | Filing → |
| NVCR | SELL | 2025-03-04 | $47K | — | Filing → |